1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US Compounding Pharmacies Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US Compounding Pharmacies Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Drug Shortage Crisis Across the World
- 5.1.2 Benefits of Compounded Medications
5.2 Market Opportunities
- 5.2.1 Growing Demand for Compounding Pharmacy During COVID-19
5.3 Future Trends
- 5.3.1 Growing Outsourcing Facilities for Manufacturing and Sales of Products
5.4 Impact of Drivers and Restraints
6. US Compounding Pharmacies Market Country Analysis
6.1 US Compounding Pharmacies Market Overview
6.2 US Compounding Pharmacies Market Revenue 2017-2027 (US$ Million)
6.3 US Compounding Pharmacies Market Forecast Analysis
7. US Compounding Pharmacies Market Analysis – by Product
7.1 Oral Medications
- 7.1.1 Overview
- 7.1.2 Oral Medications: US Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Topical Medications
- 7.2.1 Overview
- 7.2.2 Topical Medications: US Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Suppositories
- 7.3.1 Overview
- 7.3.2 Suppositories: US Compounding Pharmacies Market – Revenue and Forecast to 2031 (US$ Million)
8. US Compounding Pharmacies Market Analysis – by Therapeutic Area
8.1 Pain Medications
- 8.1.1 Overview
- 8.1.2 Pain Medications: US Compounding Pharmacies Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Hormone Replacement Therapies
- 8.2.1 Overview
- 8.2.2 Hormone Replacement Therapies: US Compounding Pharmacies Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Dermatological Applications
- 8.3.1 Overview
- 8.3.2 Dermatological Applications: US Compounding Pharmacies Market – Revenue and Forecast to 2027 (US$ Million)
9. US Compounding Pharmacies Market – United States Analysis
9.1 United States
- 9.1.1 United States: US Compounding Pharmacies Market – Revenue
and Forecast to 2027 (US$ Million)
- 9.1.1.1 United States:
US Compounding Pharmacies Market Breakdown, by Product
- 9.1.1.2 United States:
US Compounding Pharmacies Market Breakdown, by Therapeutic Area
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. US Compounding Pharmacies Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Fagron
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Triangle compounding pharmacy
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Institutional pharmacy solutions, llc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 B. Braun melsungen ag
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pharmedium services llc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Fresenius kabi ag
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Avella specialty pharmacy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Pencol Compounding Pharmacy
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Vertisis custom pharmacy
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 US Compounding Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For US Compounding Pharmacies Market
